Valuation: Sartorius AG

Market Cap 13.65B 15.7B 12.7B 11.66B 22.02B 1,499B 22.36B 150B 58.76B 746B 58.96B 57.66B 2,502B P/E 2026 *
59.1x
P/E 2027 * 44.2x
Enterprise Value 17.21B 19.8B 16.02B 14.71B 27.78B 1,890B 28.21B 189B 74.12B 941B 74.37B 72.73B 3,155B EV / Sales 2026 *
4.62x
EV / Sales 2027 * 4.14x
Free-Float
35.87%
Yield 2026 *
0.36%
Yield 2027 * 0.45%
1 day+0.36%
1 week+1.04%
1 month-2.62%
3 months+2.39%
6 months-7.12%
Current year-8.80%
1 week 216
Extreme 216
225.7
1 month 209.9
Extreme 209.9
249.8
Current year 200
Extreme 200
266
1 year 177.1
Extreme 177.1
266
3 years 169.45
Extreme 169.45
382.6
5 years 169.45
Extreme 169.45
625
10 years 63.05
Extreme 63.05
625
Manager TitleAgeSince
Chief Executive Officer 59 29/06/2025
Director of Finance/CFO 55 31/03/2024
Chief Operating Officer 70 31/12/2000
Director TitleAgeSince
Director/Board Member 62 31/08/2002
Chairman 69 18/07/2017
Director/Board Member 77 28/11/2011
Change 5-day change 1-year change 3-year change Capi.($)
+0.36%+1.04% - - 15.7B
+4.47%+7.46%+1.25%+106.27% 1.77B
+1.21%+4.49%-27.15%-80.80% 1.14B
-1.73%+2.33%-38.79%+13.42% 980M
+1.29%+7.31%-46.81%-52.67% 655M
+0.93%+7.41%-45.76%-53.34% 543M
+1.08%+2.47%+53.71%-51.95% 472M
-0.81%+1.33%-53.54%-62.03% 374M
-0.81%+5.14%-15.69%-32.94% 368M
+4.84%+12.18%+22.29%+15.09% 329M
Average +1.08%+4.04%-16.72%-22.11% 737.48M
Weighted average by Cap. +0.72%+3.19%-17.40%-1.37%

Financials

2026 *2027 *
Net sales 3.73B 4.29B 3.47B 3.19B 6.02B 409B 6.11B 40.9B 16.05B 204B 16.11B 15.75B 683B 4.08B 4.7B 3.8B 3.49B 6.59B 448B 6.69B 44.8B 17.58B 223B 17.64B 17.25B 749B
Net income 249M 287M 232M 213M 402M 27.38B 409M 2.74B 1.07B 13.63B 1.08B 1.05B 45.71B 328M 377M 305M 280M 529M 35.99B 537M 3.6B 1.41B 17.92B 1.42B 1.38B 60.08B
Net Debt 3.57B 4.1B 3.32B 3.05B 5.76B 392B 5.84B 39.13B 15.36B 195B 15.41B 15.07B 654B 3.26B 3.75B 3.04B 2.79B 5.26B 358B 5.34B 35.78B 14.04B 178B 14.09B 13.78B 598B
Logo Sartorius AG
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Employees
14,279
Date Price Change Volume
31/07/26 €222.90 +0.36% 23
30/07/26 €222.10 -1.51% 0
29/07/26 €225.50 -.--% 305
28/07/26 €225.50 +4.40% 65
27/07/26 €216.00 -2.09% 8
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
218.00EUR
Average target price
265.95EUR
Spread / Average Target
+21.99%

Quarterly revenue - Rate of surprise